Exploring assistive technology as a potential beneficial intervention tool for people with Alzheimer’s disease – a systematic review

Código QR

Exploring assistive technology as a potential beneficial intervention tool for people with Alzheimer’s disease – a systematic review

Blanka Klimova,1 Martin Valis,2 Kamil Kuca3 1Department of Applied Linguistics, Faculty of Informatics and Management, University of Hradec Kralove, Hradec Kralove, Czech Republic; 2Department of Neurology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic; 3Centre for Basic and Ap...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Klimova B, Valis M, Kuca K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	assistive technology Alzheimer’s disease patients caregivers benefits Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/8dcb434cacc947d4910b1b87efb905cc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Alzheimer’s disease and language impairments: social intervention and medical treatment
por: Klimova B, et al.
Publicado: (2015)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

Public–private partnerships improve health outcomes in individuals with early stage Alzheimer’s disease
por: Galvin JE, et al.
Publicado: (2014)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan J, et al.
Publicado: (2013)

Alzheimer's care today

Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
por: Montgomery W, et al.
Publicado: (2018)

Effectiveness of weekly cognitive stimulation therapy for people with dementia and the additional impact of enhancing cognitive stimulation therapy with a carer training program
por: Cove J, et al.
Publicado: (2014)

Effects of multiple training modalities in patients with Alzheimer’s disease: a pilot study
por: Tai SY, et al.
Publicado: (2016)

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment
por: Pai MC, et al.
Publicado: (2015)

Late onset Alzheimer’s disease in older people
por: Ahmet Turan Isik
Publicado: (2010)

Effect Of An Extra-Virgin Olive Oil Intake On The Delay Of Cognitive Decline: Role Of Secoiridoid Oleuropein?
por: Klimova B, et al.
Publicado: (2019)

Assistive technologies for managing language disorders in dementia
por: Klimova B, et al.
Publicado: (2016)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

A REVIEW OF BURDEN OF CAREGIVERS OF PATIENTS WITH ALZHEIMER'S DISEASE
por: Sayyidah Aqilah Ridzuan, et al.
Publicado: (2019)

FACTORS AFFECTING THE CARE BURDEN OF FAMILY MEMBERS PROVIDING PRIMARY CAREGIVING TO ALZHEIMER PATIENTS
por: Ümmühan KAYA UYGUN, et al.
Publicado: (2019)

Olfactory dysfunction in Alzheimer’s disease
por: Zou YM, et al.
Publicado: (2016)

Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
por: Giau VV, et al.
Publicado: (2018)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

Alzheimer's research & therapy
Publicado: (2009)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
por: Bektaş O, et al.
Publicado: (2015)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
por: Kose Ozlece H, et al.
Publicado: (2018)

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
por: Li XH, et al.
Publicado: (2015)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai Y, et al.
Publicado: (2015)

Journal of Alzheimer's disease
Publicado: (1998)

Spaced Retrieval and Episodic Memory Training in Alzheimer’s Disease
por: Small JA, et al.
Publicado: (2020)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
por: An SS, et al.
Publicado: (2016)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009)

Baicalein improves behavioral dysfunction induced by Alzheimer’s disease in rats
por: Zhou L, et al.
Publicado: (2016)

Patient characteristics associated with screening positive for Alzheimer’s disease and related dementia
por: Fowler NR, et al.
Publicado: (2018)

Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
por: Kishi T, et al.
Publicado: (2018)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
por: Jelcic N, et al.
Publicado: (2014)

Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
por: Adams CD
Publicado: (2020)

Altered diastolic function and aortic stiffness in Alzheimer’s disease
por: Çalık AN, et al.
Publicado: (2014)

Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
por: Cardoso BR, et al.
Publicado: (2013)

Quality of life predictors in informal caregivers of seniors with a functional performance deficit – an example of home care in Poland
por: Ślusarska B, et al.
Publicado: (2019)

Vitamin E and Alzheimer’s disease: what do we know so far?
por: Browne D, et al.
Publicado: (2019)

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population
por: Wu P, et al.
Publicado: (2015)

RAB10: an Alzheimer’s disease resilience locus and potential drug target
por: Tavana JP, et al.
Publicado: (2018)